Trends in use of continuous glucose monitors among individuals with type 2 diabetes enrolled in Medicare Advantage (2021–2023)

CGM utilization in an MA population increased concurrent with the expanded clinical guideline changes and Medicare coverage, though certain types of beneficiaries were more likely to use CGMs than others in 2023. Awareness of the differences in uptake of CGMs among beneficiaries could aid future education and outreach opportunities.